# Assess Efficacy in Subjects With Traumatic Spinal Cord Injury

> **NCT00667966** · PHASE4 · COMPLETED · sponsor: **Bayer** · enrollment: 45 (actual)

## Conditions studied

- Erectile Dysfunction
- Spinal Cord Injury

## Interventions

- **DRUG:** Vardenafil (Levitra, BAY 38-9456), 10 mg
- **DRUG:** Placebo
- **DRUG:** Vardenafil (Levitra, BAY 38-9456), 20 mg

## Key facts

- **NCT ID:** NCT00667966
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** —
- **Final completion:** 2007-02
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2015-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00667966

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00667966, "Assess Efficacy in Subjects With Traumatic Spinal Cord Injury". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00667966. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*